The Secretariat shall:
a) liaise with key players of medicinal and aromatic plant trade supply and value chains to raise awareness and understanding of CITES regulations for medicinal and aromatic plant species and of the impact of the trade in medicinal and aromatic plants on the conservation of CITES-listed medicinal and aromatic plant species in the wild;
b) subject to available resources, analyse challenges and opportunities in matters related to trade in medicinal and aromatic plants, including by:
i) providing an updated overview of the international trade in CITES-listed plant species traded as medicinal products, and assessing whether existing databases with trade names of CITES-listed medicinal and aromatic plant species can be linked to the CITES Checklist database;
ii) reviewing ongoing work on sustainable and traceable supply and value chains for medicinal and aromatic plant products, focusing on certification schemes, standards and guidelines;
iii) examining case studies involving local and traditional knowledge, and participatory assessments, monitoring and management of CITES-listed medicinal and aromatic plant species; and
iv) Based on the findings of i) to iii), developing recommendations to inter alia complement existing tools relating to the implementation of the Convention for CITES-listed medicinal and aromatic plants, and create synergies, as appropriate, with relevant intergovernmental organizations and stakeholders;
c) report to the Plants Committee on the outcomes of the work outlined in paragraphs a) and b).
a) liaise with key players of medicinal and aromatic plant trade supply and value chains to raise awareness and understanding of CITES regulations for medicinal and aromatic plant species and of the impact of the trade in medicinal and aromatic plants on the conservation of CITES-listed medicinal and aromatic plant species in the wild;
b) subject to available resources, analyse challenges and opportunities in matters related to trade in medicinal and aromatic plants, including by:
i) providing an updated overview of the international trade in CITES-listed plant species traded as medicinal products, and assessing whether existing databases with trade names of CITES-listed medicinal and aromatic plant species can be linked to the CITES Checklist database;
ii) reviewing ongoing work on sustainable and traceable supply and value chains for medicinal and aromatic plant products, focusing on certification schemes, standards and guidelines;
iii) examining case studies involving local and traditional knowledge, and participatory assessments, monitoring and management of CITES-listed medicinal and aromatic plant species; and
iv) Based on the findings of i) to iii), developing recommendations to inter alia complement existing tools relating to the implementation of the Convention for CITES-listed medicinal and aromatic plants, and create synergies, as appropriate, with relevant intergovernmental organizations and stakeholders;
c) report to the Plants Committee on the outcomes of the work outlined in paragraphs a) and b).